Nalagenetics offers genetic testing services utilizing microarray and qPCR technology to provide personalized health insights tailored to the Southeast Asian population. Their tests identify genetic predispositions related to nutrition, fitness, and medication compatibility, enabling individuals to make informed health decisions and optimize their wellness.
Funding
$15.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CSFounders
Product
Problem
Individuals in Southeast Asia often lack access to genetic testing tailored to their specific population, leading to less accurate and less relevant health insights. This can result in ineffective or inappropriate health and wellness decisions based on generic genetic data.
Solution
Nalagenetics offers a suite of DNA tests designed specifically for individuals of Southeast Asian descent, providing personalized insights into nutrition, fitness, medication compatibility, and disease risk. Using microarray and qPCR technology, their tests analyze genetic predispositions relevant to this population, offering more accurate and actionable information compared to standard genetic tests. Customers receive comprehensive reports detailing their genetic results, along with guidance on how to integrate these insights into their health and wellness plans. The company also provides access to health professionals for pre- and post-test consultations, ensuring individuals understand their results and can make informed decisions.
Target Audience
The primary target audience includes individuals in Southeast Asia seeking personalized health insights, as well as families looking to understand their genetic predispositions for proactive health management.
Features
- DNA tests tailored for the genetic diversity of the Southeast Asian population
- Utilizes microarray and qPCR technology for comprehensive genetic analysis
- Tests available for nutrition (NutriReady™), lifestyle (LifeReady™), breast cancer risk (MammoReady™), and medication compatibility (RxReady™)
- Identifies genetic predispositions related to metabolism, food intolerances, longevity markers, and inflammation markers
- Provides insights into medication compatibility to minimize trial and error and reduce the risk of negative reactions
- Offers personalized advice to reduce disease risk based on genetic predispositions
- Includes a non-invasive sample collection kit for at-home testing
- Delivers comprehensive digital reports accessible through a secure app